Caplight Directory>Companies>Apini Therapeutics-preview>Apini-therapeutics


Apini Therapeutics

Apini Therapeutics

Private
HuntingdonHealthcare & Life Scienceshttp://apinitherapeutics.com/

Last Round

Seed

Jun 11, 2025

Company Overview

Apini Therapeutics is a biotechnology company that develops small molecule compounds for the treatment of chronic inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

eNAMPT inhibitorsmall molecule therapeuticsinflammatory bowel diseaseIBDchronic inflammatory diseasesanti-inflammatory drugsdrug discoverypreclinical biotechnon-immunosuppressiveeNAMPT modulatorsCrohn's diseaseUlcerative Colitisbiotech spinoutcardiovascular diseasediabetes

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Apini Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Apini Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJun 11, 2025
AcceleratorNov 14, 2024
View all Funding Rounds

Apini Therapeutics Investors

Notable investors and investment history

InvestorRounds
SynconaSeed, Accelerator
Northern GritstoneSeed
The University of Manchester Innovation FactoryAccelerator
View all Investors

Apini Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Apini Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Apini Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHuntingdon
Year Founded2021
Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.